Search
for
Sort by
Research 541–570 of 1000+
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia
- Terapia antiandrogénica como quimioprevención del cáncer de próstata
- Remediation of prostrate-related disorders using polyphenols: kolaviron and quercetin in perspective
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Fluxactive Complete (#1 PREMIUM PROSTATE SUPPORT FORMULA) Managing Prostate Wellness And Bladder Functions!
- Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
- Finasteride para disminuir el sangrado en resección transuretral de próstata en pacientes con sonda Foley
- Photoacoustic imaging for prostate brachytherapy
- Finasteride and prostate cancer
- Management of Advanced Prostate Cancer Undergoing Major Shift
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride
- Urological Oncology: Prostate Cancer
- Slow progress in prostate cancer
- How not to detect prostate cancer
- Effects of the androgen receptor overexpression in prostate cancer
- TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms
- 5α-reductase activity in the prostate
- Androgen biosynthetic pathways in the human prostate
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use